Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Public ClinicalTrials.gov record NCT01938495. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-Center, Randomized Controlled Study of the NeuRx® Diaphragm Pacing System™ (DPS)In Participants With Amyotrophic Lateral Sclerosis (ALS)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is being conducted to determine if DPS treatment for people with ALS and hypoventilation is associated with improved survival or diaphragm function. The primary objective of the study is to conduct a multi-center, randomized controlled clinical trial comparing standard of care (control) to diaphragm stimulator treatment with the NeuRx® Diaphragm Pacing System™ (DPS) with respect to survival. The secondary objective of the study is to conduct a multi-center, randomized controlled clinical trial to compare standard of care treatment (control) to DPS in ALS subjects with hypoventilation.
Study identification
- NCT ID
- NCT01938495
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 52 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 2013 (Type not available)
- Primary completion
- Jan 2017 (Actual)
- Completion
- Apr 2017 (Actual)
- Last update posted
- Mar 9, 2023
2013 – 2017
United States locations
- U.S. sites
- 25
- U.S. states
- 17
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Institute | Phoenix | Arizona | — | — |
| Cedars-Sinai Medical Center | Los Angeles | California | — | — |
| California Pacific Medical Center | San Diego | California | — | — |
| Stanford University | Stanford | California | — | — |
| Hospital for Special Care | New Britain | Connecticut | — | — |
| Mayo Clinic Florida | Jacksonville | Florida | — | — |
| University of Florida, Jacksonville | Jacksonville | Florida | — | — |
| University of Iowa | Iowa City | Iowa | — | — |
| Massachusetts General Hospital | Boston | Massachusetts | — | — |
| Henry Ford Health Systems | Detroit | Michigan | — | — |
| St Louis University | St Louis | Missouri | — | — |
| Neurology Associates P.C. | Lincoln | Nebraska | — | — |
| Hospital for Special Surgery | New York | New York | — | — |
| SUNY Upstate Medical University | Syracuse | New York | — | — |
| Carolinas Health Care | Charlotte | North Carolina | — | — |
| Wake Forest University | Winston-Salem | North Carolina | — | — |
| Cleveland Clinic | Cleveland | Ohio | — | — |
| Ohio State University | Columbus | Ohio | — | — |
| Providence ALS Center | Portland | Oregon | — | — |
| Drexel University | Philadelphia | Pennsylvania | — | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | — | — |
| University of Texas Southwestern | Dallas | Texas | — | — |
| University of Texas | San Antonio | Texas | — | — |
| University of Vermont | Burlington | Vermont | — | — |
| Virginia Mason Medical Center | Seattle | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01938495, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 9, 2023 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01938495 live on ClinicalTrials.gov.